Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency

被引:169
作者
Wei, Guo [1 ,2 ]
Margolin, Adam A. [1 ]
Haery, Leila [1 ]
Brown, Emily [1 ]
Cucolo, Lisa [1 ]
Julian, Bina [1 ]
Shehata, Shyemaa [3 ]
Kung, Andrew L. [2 ]
Beroukhim, Rameen [1 ,3 ]
Golub, Todd R. [1 ,2 ,4 ]
机构
[1] Broad Inst Massachusetts Inst Technol & Harvard U, Canc Program, Cambridge, MA 02142 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
IMMUNOHISTOCHEMICAL ANALYSIS; REGULATORY NETWORKS; FAMILY PROTEINS; UP-REGULATION; APOPTOSIS; EXPRESSION; RESISTANCE; INHIBITOR; BAX; DOXORUBICIN;
D O I
10.1016/j.ccr.2012.02.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
MCL1, which encodes the antiapoptotic protein MCL1, is among the most frequently amplified genes in human cancer. A chemical genomic screen identified compounds, including anthracyclines, that decreased MCL1 expression. Genomic profiling indicated that these compounds were global transcriptional repressors that preferentially affect MCL1 due to its short mRNA half-life. Transcriptional repressors and MCL1 shRNAs induced apoptosis in the same cancer cell lines and could be rescued by physiological levels of ectopic MCL1 expression. Repression of MCL1 released the proapoptotic protein BAK from MCL1, and Bak deficiency conferred resistance to transcriptional repressors. A computational model, validated in vivo, indicated that high BCL-xL expression confers resistance to MCL1 repression, thereby identifying a patient-selection strategy for the clinical development of MCL1 inhibitors.
引用
收藏
页码:547 / 562
页数:16
相关论文
共 45 条
[1]
The Bcl-2 apoptotic switch in cancer development and therapy [J].
Adams, J. M. ;
Cory, S. .
ONCOGENE, 2007, 26 (09) :1324-1337
[2]
Rapid turnover of Mcl-1 couples translation to cell survival and apoptosis [J].
Adams, Kenneth W. ;
Cooper, Geoffrey M. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (09) :6192-6200
[3]
Reverse engineering of regulatory networks in human B cells [J].
Basso, K ;
Margolin, AA ;
Stolovitzky, G ;
Klein, U ;
Dalla-Favera, R ;
Califano, A .
NATURE GENETICS, 2005, 37 (04) :382-390
[4]
The landscape of somatic copy-number alteration across human cancers [J].
Beroukhim, Rameen ;
Mermel, Craig H. ;
Porter, Dale ;
Wei, Guo ;
Raychaudhuri, Soumya ;
Donovan, Jerry ;
Barretina, Jordi ;
Boehm, Jesse S. ;
Dobson, Jennifer ;
Urashima, Mitsuyoshi ;
Mc Henry, Kevin T. ;
Pinchback, Reid M. ;
Ligon, Azra H. ;
Cho, Yoon-Jae ;
Haery, Leila ;
Greulich, Heidi ;
Reich, Michael ;
Winckler, Wendy ;
Lawrence, Michael S. ;
Weir, Barbara A. ;
Tanaka, Kumiko E. ;
Chiang, Derek Y. ;
Bass, Adam J. ;
Loo, Alice ;
Hoffman, Carter ;
Prensner, John ;
Liefeld, Ted ;
Gao, Qing ;
Yecies, Derek ;
Signoretti, Sabina ;
Maher, Elizabeth ;
Kaye, Frederic J. ;
Sasaki, Hidefumi ;
Tepper, Joel E. ;
Fletcher, Jonathan A. ;
Tabernero, Josep ;
Baselga, Jose ;
Tsao, Ming-Sound ;
Demichelis, Francesca ;
Rubin, Mark A. ;
Janne, Pasi A. ;
Daly, Mark J. ;
Nucera, Carmelo ;
Levine, Ross L. ;
Ebert, Benjamin L. ;
Gabriel, Stacey ;
Rustgi, Anil K. ;
Antonescu, Cristina R. ;
Ladanyi, Marc ;
Letai, Anthony .
NATURE, 2010, 463 (7283) :899-905
[5]
Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance [J].
Bewry, Nadine N. ;
Nair, Rajesh R. ;
Emmons, Michael F. ;
Boulware, David ;
Pinilla-Ibarz, Javier ;
Hazlehurst, Lori A. .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (10) :3169-3175
[6]
Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-kB Activation and De novo Gene Transcription [J].
Buggins, Andrea G. S. ;
Pepper, Chris ;
Patten, Piers E. M. ;
Hewamana, Saman ;
Gohil, Satyen ;
Moorhead, Jane ;
Folarin, Najeem'deen ;
Yallop, Deborah ;
Thomas, N. Shaun B. ;
Mufti, Ghulam J. ;
Fegan, Chris ;
Devereux, Stephen .
CANCER RESEARCH, 2010, 70 (19) :7523-7533
[7]
Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death [J].
Chen, R ;
Keating, MJ ;
Gandhi, V ;
Plunkett, W .
BLOOD, 2005, 106 (07) :2513-2519
[8]
Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing bak activation and bax translocation [J].
Chen, Shuang ;
Dai, Yun ;
Harada, Hisashi ;
Dent, Paul ;
Grant, Steven .
CANCER RESEARCH, 2007, 67 (02) :782-791
[9]
Cell death: Critical control points [J].
Danial, NN ;
Korsmeyer, SJ .
CELL, 2004, 116 (02) :205-219
[10]
Multifactorial Approach to Predicting Resistance to Anthracyclines [J].
Desmedt, Christine ;
Di Leo, Angelo ;
de Azambuja, Evandro ;
Larsimont, Denis ;
Haibe-Kains, Benjamin ;
Selleslags, Jean ;
Delaloge, Suzette ;
Duhem, Caroline ;
Kains, Jean-Pierre ;
Carly, Birgit ;
Maerevoet, Marie ;
Vindevoghel, Anita ;
Rouas, Ghislane ;
Lallemand, Francoise ;
Durbecq, Virginie ;
Cardoso, Fatima ;
Salgado, Roberto ;
Rovere, Rodrigo ;
Bontempi, Gianluca ;
Michiels, Stefan ;
Buyse, Marc ;
Nogaret, Jean-Marie ;
Qi, Yuan ;
Symmans, Fraser ;
Pusztai, Lajos ;
D'Hondt, Veronique ;
Piccart-Gebhart, Martine ;
Sotiriou, Christos .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (12) :1578-1586